Epidemiology and Management of Hepatocellular Carcinoma

Laura Kulik, Hashem B. El-Serag*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

781 Scopus citations


The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice are becoming increasingly related to sustained virological response after hepatitis C, suppressed hepatitis B virus during treatment, and alcoholic and nonalcoholic fatty liver disease. We review the emerging data on the risk and determinants of HCC in these conditions and the implications of HCC surveillance. However, from a public health perspective, active hepatitis C and B continue to drive most of the global burden of HCC. In United States, the age-adjusted incidence rates of HCC in Hispanics have surpassed those of HCC in Asians. Prognosis in HCC is complex because of the competing risk imposed by underlying cirrhosis and presence of malignancy. In addition to tumor burden, liver function and performance status; additional parameters including tumor biopsy, serum markers, and subclassification of current staging systems; and taking into account patterns of tumor progression may improve patient selection for therapy. Advancements in the treatment of HCC have included identification of patients who are most likely to derive a clinically significant benefit from the available therapeutic options. Additionally, the combination strategies of locoregional therapies and/or systemic therapy are being investigated.

Original languageEnglish (US)
Pages (from-to)477-491.e1
Issue number2
StatePublished - Jan 2019


  • Epidemiology
  • Hepatitis C
  • Hepatocellular Carcinoma

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Epidemiology and Management of Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Cite this